Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Clinical Trial Dosing Data AOD-9604 has been evaluated across multiple administration routes and dosing regimens
Medications require eligibility and a prescription
Improved Metabolic Health : Lowers blood sugar levels, reduces cholesterol, and improves overall metabolic markers
TRIUMPH-2 (NCT05929079) will assess bodyweight change in people with overweight/obesity and T2D and include a subset of participants with OSA, in which AHI will also be investigated as a primary endpoint
17 Amla also demonstrates antiplatelet activity in patients with type 2 diabetes (reduced platelet aggregation
US$ 21.92
US$ 29.96
US$ 29.73
US$ 23.96
US$ 28.08
US$ 23.80
US$ 29.95
US$ 28.81
